交易中 10-31 11:31:15 美东时间
0.000
0.00%
 华盛通
华盛通Aveanna Healthcare Holding Inc. (NASDAQ: AVAH) announced a secondary offering of 10 million shares of its common stock at $9 per share, with an option for underwriters to purchase up to an additional 1.5 million shares. The Selling Stockholders, affiliated with J.H. Whitney Equity Partners VII, LLC, will receive all proceeds. Aveanna is not offering shares or receiving proceeds. The offering is expected to settle on October 23, 2025. Jefferies an...
10-22 01:50
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced on July 17, 2025, that it will release its second quarter 2025 financial results before the market open on Thursday, August 7, 2025. A conference call will be held at 10:00 a.m. Eastern Time on the same day. Interested parties may join the call by dialing 1-877-407-0789 (US/Canada) or 1-201-689-8562 (international), with passcode 13754011. A replay will be available three hours after the c...
07-17 10:30
英飞凌成首个推出汽车级RISC-VMCU的厂商 3月,英飞凌宣布,计划在未来几年推出基于RISC-V的全新汽车微控制器,引领RISC-V技术在汽车行业的应用...
04-24 20:30
KalVista Pharmaceuticals (NASDAQ:KALV) announces the appointment of Jeb Ledell as COO. Most recently, Ledell served as COO at AVEO Oncology, an LG Chem company. Furthermore, Ledell was granted inducem...
2024-12-16 20:10
LG化学和LG化学旗下公司AVEO Oncology宣布,已在美国招募了首位患者进行LB-LR1109(NCT06332755;LG项目代码LR19155),...
2024-06-14 15:19
TORONTO, March 12, 2024 /PRNewswire/ - Pineapple Financial Inc. (NYSE American: PAPL), ("the Company or "Pineapple"), a tech-focused mortgage brokerage with an integrated network of partner ...
2024-03-12 20:05
LG化学官微消息,旗下抗癌新药研发公司AVEO Pharmaceuticals将在美国正式启动头颈癌新药Ficlatuzumab的Ⅲ期临床试验(试验名称:FI...
2024-01-17 11:21
Internationally recognized immuno-oncology and cell therapy executive with 20 y...
2023-12-07 01:00
NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced...
2023-11-03 04:15
NEW YORK, Sept. 27, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today details...
2023-09-27 21:05